We are live on ! Find out more
VCAM

Van Cleef Asset Management Portfolio holdings

AUM $929M
1-Year Est. Return 13.28%
This Fund
S&P 500
This Quarter Est. Return
+0.09%
1 Year Est. Return
+13.28%
3 Year Est. Return
+81.14%
5 Year Est. Return
+107.01%
10 Year Est. Return
+411.96%
AUM
$454M
AUM Growth
-$1.17M
Cap. Flow
+$1.11M
Cap. Flow %
0.24%
Top 10 Hldgs %
53.88%
Holding
117
New
3
Increased
21
Reduced
62
Closed
5

Top Sells

Rank Stock Value
1
PGR icon
Progressive
PGR
+$2.7M
2
SCHW
Charles Schwab
SCHW
+$1.86M
3
RTX icon
RTX Corp
RTX
+$1.81M
4
SYK icon
Stryker
SYK
+$911K
5
MSFT icon
Microsoft
MSFT
+$811K

Sector Composition

Rank Sector Weight
1 Financials 23.2%
2 Technology 18.99%
3 Healthcare 10.38%
4 Communication Services 7.27%
5 Consumer Staples 5.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WY icon
26
Weyerhaeuser
WY
$17.3B
$5.03M 1.11%
181,398
+4,034
+2% +$105K
SLB icon
27
SLB Ltd
SLB
$77.8B
$4M 0.88%
117,148
+571
+0.5% +$20.9K
PFE icon
28
Pfizer
PFE
$140B
$3.78M 0.83%
110,857
-413
-0.4% -$15K
CL icon
29
Colgate-Palmolive
CL
$72.6B
$3.19M 0.7%
43,400
-1,200
-3% -$87.1K
VEA icon
30
Vanguard FTSE Developed Markets ETF
VEA
$226B
$2.94M 0.65%
71,545
-1,934
-3% -$79K
SCHX icon
31
Schwab US Large- Cap ETF
SCHX
$70.9B
$2.89M 0.64%
244,656
-2,598
-1% -$30.6K
PG icon
32
Procter & Gamble
PG
$343B
$2.76M 0.61%
22,165
-746
-3% -$88.1K
BSV icon
33
Vanguard Short-Term Bond ETF
BSV
$44.6B
$2.73M 0.6%
33,762
+3,420
+11% +$276K
MRK icon
34
Merck
MRK
$324B
$2.64M 0.58%
32,838
-197
-0.6% -$15.8K
CSCO icon
35
Cisco
CSCO
$450B
$2.63M 0.58%
53,210
-786
-1% -$40.9K
VT icon
36
Vanguard Total World Stock ETF
VT
$76.3B
$2.44M 0.54%
32,644
-525
-2% -$39.2K
ADP icon
37
Automatic Data Processing
ADP
$100B
$2.35M 0.52%
14,561
-400
-3% -$66.1K
VZ icon
38
Verizon
VZ
$194B
$2.16M 0.48%
35,724
-242
-0.7% -$13.9K
JPM icon
39
JPMorgan Chase
JPM
$939B
$2M 0.44%
16,961
-129
-0.8% -$14.6K
UNH icon
40
UnitedHealth
UNH
$382B
$1.87M 0.41%
8,599
-278
-3% -$67.1K
SCHB icon
41
Schwab US Broad Market ETF
SCHB
$42.8B
$1.75M 0.39%
148,098
-40,350
-21% -$477K
BA icon
42
Boeing
BA
$165B
$1.71M 0.38%
4,501
-860
-16% -$307K
BRK.B icon
43
Berkshire Hathaway Class B
BRK.B
$1.07T
$1.59M 0.35%
7,639
-36
-0.5% -$7.42K
HIW icon
44
Highwoods Properties
HIW
$3.71B
$1.57M 0.35%
34,875
BLK icon
45
Blackrock
BLK
$164B
$1.5M 0.33%
3,376
+185
+6% +$82.4K
VBR icon
46
Vanguard Small-Cap Value ETF
VBR
$37.1B
$1.4M 0.31%
10,840
+3,770
+53% +$483K
CAT icon
47
Caterpillar
CAT
$409B
$1.31M 0.29%
10,380
-340
-3% -$43.2K
T icon
48
AT&T
T
$165B
$1.23M 0.27%
43,103
-11,243
-21% -$298K
ABT icon
49
Abbott
ABT
$180B
$1.06M 0.23%
12,725
-75
-0.6% -$6.37K
INTC icon
50
Intel
INTC
$466B
$1.04M 0.23%
20,200
+200
+1% +$9.83K

Similar funds

Van Cleef Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Van Cleef Asset Management held 117 positions worth $454M, down 0.26% from $455M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Van Cleef Asset Management's Q3 2019 filing shows 3 new, 21 increased, 62 reduced and 5 closed positions. Its largest new stake was CVS Health: 93,761 shares worth $5.91M. The largest sale was Progressive, an estimated $2.7M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.

  • Van Cleef Asset Management's largest Q3 2019 buy was CVS Health: 93,761 shares worth $5.91M.
  • Van Cleef Asset Management added most to Vanguard FTSE Emerging Markets ETF in Q3 2019, an estimated $3.28M increase.
  • Van Cleef Asset Management's biggest Q3 2019 reduction was Progressive, cutting an estimated $2.7M.
  • Van Cleef Asset Management fully exited RTX Corp in Q3 2019, selling an estimated $1.81M.
  • Van Cleef Asset Management's ten largest holdings make up 54% of its $454M portfolio in Q3 2019.
  • Van Cleef Asset Management opened 3 new positions and closed 5 in Q3 2019.
  • Van Cleef Asset Management's portfolio value fell 0.26% quarter-over-quarter to $454M.

Based on Van Cleef Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.